Month December 2024

PureTech studies optimistic LYT-200 trial ends in AML/MDS

SAN DIEGO – PureTech Well being plc (NASDAQ:PRTC, LSE:PRTC) shared promising information from a Section 1b trial of LYT-200, a novel anti-galectin-9 monoclonal antibody, on the American Society of Hematology (ASH) Annual Assembly. The trial concerned sufferers with relapsed or…

Getech, NHV kind pure hydrogen collaboration

LONDON – Getech Group plc, a supplier of subsurface useful resource location providers, has introduced a strategic collaboration with Pure Hydrogen Ventures (NHV), an funding fund specializing in pure hydrogen. The partnership goals to bolster each firms’ positions within the…